Browse by Medical Category
Talk to an access nurse today
Our program is internationally known for its level of expertise in all areas of diagnosis and care, access to clinical trials, and state-of-the-art transfusion and blood product support.
Among our key distinguishing factors are:
Every patient treated at the Center for Leukemia has a team of specialists that coordinates every aspect of his or her care. Leukemia is treated, in most cases, with chemotherapy alone, managed by medical oncologists. The medical hematologists/oncologists at the Center for Leukemia each have a high level of sub-specialization. Patients are matched with hematologists/oncologists who have distinct expertise in treating their particular type of cancer.
The Center for Leukemia is closely affiliated with the Bone Marrow Transplantation Program, where innovative techniques such as umbilical cord blood transfusion and the ability to conduct a transplant with a mismatched family donor offer more options to patients.
Effective treatment and good outcomes depend on an accurate diagnosis. The hematopathologists at the Center for Leukemia are world-renowned for their expertise in the diagnosis of various types of leukemia. Due to its reputation, our pathology department examines a large number of tissue samples. This amount enables each pathologist to develop a specialized knowledge, keep up-to-date on new research, and offer second opinions.
The pathology department has state-of-the art technology, including:
Every patient treated at the Center for Leukemia has a multidisciplinary team of specialists that coordinates every aspect of his or her care.
Program Director, Center for LeukemiaAssistant Professor of Medicine, Harvard Medical School
Clinical Director, Center for LeukemiaAssistant in Medicine
Leukemia is a type of cancer in which certain white blood cells grow out of control and spread through the blood stream. These white blood cells are made in the bone marrow. Bone marrow is the spongy material in the center of bones where our blood cells are formed. The leukemia blood cells are not normal and cannot do their usual work. They also interfere with other blood cells working properly. There are four main types of Leukemia that are grouped and named by:
The four most common types of Leukemia are called:
Learn more about Leukemia
Clinical trials are research studies of new drugs, new combinations of drugs or already approved drugs being studied to treat patients in new/different ways. They may include new drug doses or new ways (schedules) to give the drugs. Clinical trials are run under strict guidelines. Their purpose is to help find out whether new cancer treatments are safe and effective or better than the standard (current) treatment. At Massachusetts General Hospital Cancer Center, there are several clinical trials open for the treatment of leukemia that use the latest in cancer treatments.
Cancer is increasingly becoming a disease in which the genetic make-up of each individual cancer drives therapy. The Center for Leukemia also has access to clinical trials involving these targeted therapy approaches.
View leukemia team members honored for their commitment to the fight against cancer.
Amir T. Fathi, MD
Caring for a Cure
Ellen Fitzgerald, RN
Timothy Graubert, MD
Steven McAfee, MD
If you have any questions or would like to speak with one of our physicians, please call the Center for Leukemia at Massachusetts General Hospital Cancer Center at 617 724 1124.
Back to Top